Evaluate the Oncomine™ Immune Response Research Assay by sending samples to OmniSeq®, a CLIA licensed laboratory.

About Oncomine™ Immune Response Research Assay

 

  • Targeted, pan-cancer gene expression assay designed for the Ion Torrent™ next-generation sequencing (NGS) platform
  • Designed to interrogate the tumor microenvironment to enable mechanistic studies and identification of predictive biomarkers for immunotherapy
  • Optimized to measure the expression of genes involved in tumor-immune interactions, including the low-expressing genes involved in inflammatory signaling
  • Can be run with DNA-Seq to provide mutation burden (MuB) for complete immuno-oncology profile

To order Oncomine™ Immune Response Research Assay or for more information call (800) 781-1259 or fill in the form below. An OmniSeq representative will contact you as soon as possible.

Option 1 – OmniSeq® pays you $500

  • For specimens from patients treated with checkpoint inhibitors, you provide information on the specimen and patient outcome data under Omniseq’s IRB-approved research protocol
  • OmniSeq® will send you a data summary report
  • Includes DNA-seq Mutation Burden (MuB)

Option 2 – OmniSeq® will run OIRRA for Free

  • For specimens from patients treated with checkpoint inhibitors, you provide information on the specimen and patient outcome data under Omniseq’s IRB-approved research protocol
  • OmniSeq® will send you the raw data files
  • Includes DNA-seq Mutation Burden (MuB)

Option 3 – Order OIRRA from OmniSeq® for $1000

• You provide no information to OmniSeq®
• You receive OIRRA raw data files for use under your research protocol
• DNA-Seq Mutation Burden (MuB) provided for free

Contact Name *

Organization *

Phone *

Email *

Number of Samples *

Option